PURPOSE: Ultrasound can be used to release a therapeutic payload encapsulated within a perfluorocarbon (PFC) emulsion via acoustic droplet vaporization (ADV), a process whereby the PFC phase is vaporized and the agent is released. ADV-generated microbubbles have been previously used to selectively occlude blood vessels in vivo. The coupling of ADV-generated drug delivery and occlusion has therapeutically synergistic potentials. METHODS: Micron-sized, water-in-PFC-in-water (W(1)/PFC/W(2)) emulsions were prepared in a two-step process using perfluoropentane (PFP) or perfluorohexane (PFH) as the PFC phase. Fluorescein or thrombin was contained in the W(1) phase. RESULTS: Double emulsions containing fluorescein in the W(1) phase displayed a 5.7±1.4-fold and 8.2±1.3-fold increase in fluorescein mass flux, as measured using a Franz diffusion cell, after ADV for the PFP and PFH emulsions, respectively. Thrombin was stably retained in four out of five double emulsions. For three out of five formulations tested, the clotting time of whole blood decreased, in a statistically significant manner (p < 0.01), when incubated with thrombin-loaded emulsions exposed to ultrasound compared to emulsions not exposed to ultrasound. CONCLUSIONS: ADV can be used to spatially and temporally control the delivery of water-soluble compounds formulated in PFC double emulsions. Thrombin release could extend the duration of ADV-generated, microbubble occlusions.
PURPOSE: Ultrasound can be used to release a therapeutic payload encapsulated within a perfluorocarbon (PFC) emulsion via acoustic droplet vaporization (ADV), a process whereby the PFC phase is vaporized and the agent is released. ADV-generated microbubbles have been previously used to selectively occlude blood vessels in vivo. The coupling of ADV-generated drug delivery and occlusion has therapeutically synergistic potentials. METHODS: Micron-sized, water-in-PFC-in-water (W(1)/PFC/W(2)) emulsions were prepared in a two-step process using perfluoropentane (PFP) or perfluorohexane (PFH) as the PFC phase. Fluorescein or thrombin was contained in the W(1) phase. RESULTS: Double emulsions containing fluoresceinin the W(1) phase displayed a 5.7±1.4-fold and 8.2±1.3-fold increase influorescein mass flux, as measured using a Franz diffusion cell, after ADV for the PFP and PFH emulsions, respectively. Thrombin was stably retained in four out of five double emulsions. For three out of five formulations tested, the clotting time of whole blood decreased, in a statistically significant manner (p < 0.01), when incubated with thrombin-loaded emulsions exposed to ultrasound compared to emulsions not exposed to ultrasound. CONCLUSIONS: ADV can be used to spatially and temporally control the delivery of water-soluble compounds formulated inPFC double emulsions. Thrombin release could extend the duration of ADV-generated, microbubble occlusions.
Authors: M Zhang; M L Fabiilli; K J Haworth; J B Fowlkes; O D Kripfgans; W W Roberts; K A Ives; P L Carson Journal: Ultrasound Med Biol Date: 2010-10 Impact factor: 2.998
Authors: Roger L Lundblad; Ralph A Bradshaw; Don Gabriel; Thomas L Ortel; Jeffrey Lawson; Kenneth G Mann Journal: Thromb Haemost Date: 2004-05 Impact factor: 5.249
Authors: Mitra Aliabouzar; Christopher D Davidson; William Y Wang; Oliver D Kripfgans; Renny T Franceschi; Andrew J Putnam; J Brian Fowlkes; Brendon M Baker; Mario L Fabiilli Journal: Soft Matter Date: 2020-07-22 Impact factor: 3.679
Authors: Catherine M Carneal; Oliver D Kripfgans; Jochen Krücker; Paul L Carson; J Brian Fowlkes Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2011-09 Impact factor: 2.725
Authors: Xiaofang Lu; Xiaoxiao Dong; Sam Natla; Oliver D Kripfgans; J Brian Fowlkes; Xueding Wang; Renny Franceschi; Andrew J Putnam; Mario L Fabiilli Journal: Ultrasound Med Biol Date: 2019-06-22 Impact factor: 2.998
Authors: David Bardin; Thomas D Martz; Paul S Sheeran; Roger Shih; Paul A Dayton; Abraham P Lee Journal: Lab Chip Date: 2011-10-20 Impact factor: 6.799
Authors: Khoi Nguyen; Hsuan-Yeh Pan; Kevin Haworth; Eric Mahoney; Karla P Mercado-Shekhar; Chia-Ying Lin; Zhe Zhang; Yoonjee C Park Journal: Ultrasound Med Biol Date: 2018-10-26 Impact factor: 2.998
Authors: Benjamin A Juliar; Melissa M Bromley; Alexander Moncion; Denise C Jones; Eric G O'Neill; Christopher G Wilson; Renny T Franceschi; Mario L Fabiilli Journal: Adv Healthc Mater Date: 2016-05-18 Impact factor: 9.933
Authors: Mario L Fabiilli; Christopher G Wilson; Frédéric Padilla; Francisco M Martín-Saavedra; J Brian Fowlkes; Renny T Franceschi Journal: Acta Biomater Date: 2013-03-25 Impact factor: 8.947
Authors: Mario L Fabiilli; Morand R Piert; Robert A Koeppe; Phillip S Sherman; Carole A Quesada; Oliver D Kripfgans Journal: Contrast Media Mol Imaging Date: 2013 Jul-Aug Impact factor: 3.161